Carregant...

Metyrapone in treatment-resistant depression

Depression affects a significant proportion of the population, with 1-year and lifetime prevalence of 3–5% and 10–30% respectively. Full remission is achieved in only a third of patients following treatment with first-line antidepressant. There is a need for novel treatments for treatment-resistant...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Sigalas, Paul David, Garg, Himanshu, Watson, Stuart, McAllister-Williams, Richard Hamish, Ferrier, I. Nicol
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2012
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3736936/
https://ncbi.nlm.nih.gov/pubmed/23983967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045125312436597
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!